The MARVIN Chatbots to Provide Information for Different Health Conditions
Recruiting now · Not applicable
Conditions studied: HIV Infections, Breast Cancer, Pediatric Emergency Medicine
In brief
This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast cancer) and populations (e.g. pharmacists). Therefore, this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots. The investigators adopt an adaptive platform trial design, which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal of ineffective trial arms based on interim data (implementation outcomes) and introduction of new trial arms.
Key facts
- Study ID
- NCT05789901
- Run by
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- People needed
- 400
- Starts
- 2024-03-01
- Expected to finish
- 2034-12-31
- Last updated by the study team
- 2024-03-06
Who can join
Age: 14 and older. Sex: any. Healthy volunteers: accepted.
You may not qualify if…
- not meeting the inclusion criteria
- any reason, in the opinion of the investigator, which would make the candidate inappropriate for participation in an investigative study involving a chatbot (e.g., cognitive deficit)
Where it is running
- Centre hospitalier de l'Université de Montréal (CHUM) — Montreal, Quebec, Canada (enrolling)
- McGill University Health Centre (MUHC) — Montreal, Quebec, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.